Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2023 Jul 5;11(7):e006814corr1. doi: 10.1136/jitc-2023-006814corr1

Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

PMCID: PMC10335405  PMID: 37407238

Fa'ak F, Buni M, Falohun A, et al. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J Immunother Cancer 2023;11:e006814. doi: 10.1136/jitc-2023-006814

In the original publication, Noha Abdel-Wahab had not been listed as a corresponding author. This has now been corrected.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES